Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

Narrow- and broad-band spectral changes after hemispherotomy in an awake representative patient, displaying marked electroencephalography (EEG) slowing of the isolated cortex. by Michele Angelo Colombo (22446342)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

“…<b>(E)</b> Following surgery, the PSD became steeper in the disconnected cortex, as indexed by a significant pre- to post-decrease in Spectral Exponent toward more negative values, observed in all patients (i.e., all negative post-pre differences for the disconnected cortex). …”

Anti-SjLLPi1 antibody treatment decreases worm burden in mice 7 days after <i>S. japonicum</i> infection. by Fanyan Chen (3909178)

Occupancy model results using habitat as a covariate that affects occupancy, detection probability, or both (pre-COVID conditions only). by Ishana Shukla (20189612)

Subjects:

Synchronization of the vegetative cycle and SP formation in <i>Eudorina.</i> by Hiroko Kawai-Toyooka (382362)

Data Sheet 1_Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.pdf by Jingjing Fang (124938)

The comparison of the Spectral Exponent in hemispherotomy with a reference pediatric sample across wakefulness and NREM Sleep reveal values compatible with deep sleep in the isolat... by Michele Angelo Colombo (22446342)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Pre-Experiment. by Nan Tang (642590)

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>a</b> VEGF-A121 exhibited a change of –173.2, 95% CI [–322.8, –96.3], <i>p</i> = 0.00049, where the addition of 2 μg/mL bevacizumab markedly reduced the VEGF-A121 concentration to a median of 26.9 pg/mL, with a range of 67.3 pg/mL that partly fell below the high-accuracy threshold of 38 pg/mL. …”

Store listing metrics and user acquisition. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

Installation, growth, and retention metrics. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

Implemented activities. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

App user retention trends. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

App user onboarding trends. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

App user base growth trends. by Henri Claude Moungui (22227043)

“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)